Christopher Simon - 30 May 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Reporting relationship: President & CEO, Director
Issuer ticker: HAE
Reported as of: 30 May 2025
Net transaction value: -$1,820,115
SEC form: 4
Accepted by SEC: 03 Jun 2025, 16:41:44 UTC
Prior SEC filing: 27 May 2025
Next SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon

Key filing fact

Christopher Simon filed Form 4 for HAEMONETICS CORP (HAE) on 03 Jun 2025.

Key facts

This page summarizes Christopher Simon's Form 4 filing for HAEMONETICS CORP (HAE).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2025, 16:41.

Change

Previous filing in this sequence was filed on 27 May 2025.
Current net transaction value: -$1,820,115.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001674993 Primary reporting owner

Simon, Christopher

Relationship: President & CEO, Director
Address: 125 SUMMER STREET, BOSTON
Signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Signature date: 03 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HAE transaction

Common Stock

Award

Transaction value: $0
Shares: +66,666
Change %: +20%
Price: $0.000000
Shares after: 401,778
Date: 30 May 2025
Ownership: Direct
Footnotes: F1, F2

HAE transaction

Common Stock

Tax liability

Transaction value: $1,820,115
Shares: -26,234
Change %: -6.5%
Price: $69.38
Shares after: 375,544
Date: 30 May 2025
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025.

Footnote F2

This number includes unvested restricted stock units ("RSUs") previously reported.

Footnote F3

Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.